Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000673610 | SCV000798834 | likely pathogenic | Peroxisome biogenesis disorder 6A (Zellweger); Peroxisome biogenesis disorder 6B | 2018-03-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001048988 | SCV001213019 | pathogenic | Peroxisome biogenesis disorder, complementation group 7 | 2022-07-06 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ser251*) in the PEX10 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PEX10 are known to be pathogenic (PMID: 9683594, 10862081, 21031596). This variant is present in population databases (rs768893724, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with PEX10-related conditions. ClinVar contains an entry for this variant (Variation ID: 557464). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV004568558 | SCV005055236 | likely pathogenic | Peroxisome biogenesis disorder 6A (Zellweger) | 2024-03-09 | criteria provided, single submitter | clinical testing |